Clinical Trial Update: Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary Hyperparathyroidism [Phase 4]

View source ↗

Summary

The document summarizes a completed Phase 4 study evaluating safety and efficacy of doxercalciferol in patients with chronic kidney disease stage 3-4 and second…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Drugs mentioned

• Hectorol (doxercalciferol)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Secondary Hyperparathyroidism, Renal Failure | Phase 4 | Status: COMPLETED